✦ LIBER ✦

Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III–IV epithelial ovarian cancer a multicenter, randomized study

✍ Scribed by Giorgio Bolis; Giovanna Scarfone; Francesco Raspagliesi; Giorgia Mangili; Saverio Danese; Paolo Scollo; Domenica Lo Russo; Antonella Villa; Paola Daniela Aimone; Giovanni Scambia

Book ID: 116430461
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 543 KB
Volume: 46
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2010.06.124

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A pilot study of docetaxel-carboplatin v

A pilot study of docetaxel-carboplatin versus paclitaxel-carboplatin in Japanese patients with epithelial ovarian cancer

✍ Taisuke Mori; Kenichi Hosokawa; Yoshiyuki Kinoshita; Ai Watanabe; Takeshi Yamagu 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 271 KB

Epirubicin/paclitaxel/carboplatin (TEC)

Epirubicin/paclitaxel/carboplatin (TEC) vs paclitaxel/carboplatin (TC) in first-line treatment of ovarian cancer FIGO stages IIB–IV. Results of a randomized AGO-GINECO GCIG Intergroup phase III trial

✍ E. PUJADE-LAURAINE; A. du BOIS; A. GOUPIL; J. ROCHON; V. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB

Cisplatin/paclitaxel vs. carboplatin/pac

Cisplatin/paclitaxel vs. carboplatin/paclitaxel in 798 patients with ovarian cancer FIGO IIB-IV — Randomized phase III study the AGO (Arbeitsgemeinschaft Gynaekologische Onkologie) study group (OVAR-3 trial)

✍ Costa, S.D.; du Bois, A.; Lueck, H.J.; Meier, W.; Moebus, V.; Bauknecht, T.; Ric 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 197 KB

A phase II study of paclitaxel, carbopla

A phase II study of paclitaxel, carboplatin, and gemcitabine in previously untreated patients with epithelial ovarian cancer FIGO stage IC–IV (AGO-OVAR protocol OVAR-8)

✍ A. du Bois; A. Belau; U. Wagner; J. Pfisterer; B. Schmalfeldt; B. Richter; A. St 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 302 KB

O-217 A randomized phase III trial of ge

O-217 A randomized phase III trial of gemcitabine (G) in combination with carboplatin (C) or paclitaxel (P) versus paclitaxel plus carboplatin in advanced (Stage IIIB, IV) Non-Small Cell Lung Cancer (NSCLC)

✍ Treat, Joe; Chandra, Belani P.; Edelman, Martin; Socinski, Mark; Gonin, R.; Ansa 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 170 KB

36 Paclitaxel/Carboplatin(TC) vs Paclita

36 Paclitaxel/Carboplatin(TC) vs Paclitaxel/Carboplatin sequentially followed by Topotecan (TC-Top) in first-line treatment of ovarian cancer Flgo stages IIB – IV interim results of a gynaecologic cancer intergroup phase III trial of the Ago ovarian cancer study group and Gineco

✍ E. Pujade-Lauraine; J. Pfisterer; A. Lortholary; R. Kimmig; B. Weber; A. du Bois 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 168 KB